Prenetics
From Wikipedia, the free encyclopedia
Company typePublic
ISINKYG722451229
Industry
- Consumer Health
- Health and Wellness
- Genetic Testing
- DNA Sequencing
| Company type | Public |
|---|---|
| Nasdaq: PRE | |
| ISIN | KYG722451229 |
| Industry |
|
| Founded | 2014 |
| Founders |
|
| Headquarters | |
Key people | Danny Yeung (CEO)[1] |
| Website | prenetics |
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
Its subsidiary brands include CircleDNA, Insighta and IM8.
One of the company's major investors was Alibaba founder Jack Ma.[2]
After listing, it struggled to turn a profit.[3][4] In October 2023 it announced a 1 for 15 reverse stock split so it could regain the stock exchange's required US$1 per share stock price.[5]
Prenetics became the first Hong Kong based unicorn to list on Nasdaq following a merger with a Special-purpose acquisition company Artisan Acquisition Corp.[6][7]